PT1730147E - Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade - Google Patents
Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade Download PDFInfo
- Publication number
- PT1730147E PT1730147E PT05716285T PT05716285T PT1730147E PT 1730147 E PT1730147 E PT 1730147E PT 05716285 T PT05716285 T PT 05716285T PT 05716285 T PT05716285 T PT 05716285T PT 1730147 E PT1730147 E PT 1730147E
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- triazaspiro
- decan
- treatment
- obesity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Confectionery (AREA)
- General Preparation And Processing Of Foods (AREA)
- Seasonings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004014296A DE102004014296A1 (de) | 2004-03-22 | 2004-03-22 | Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1730147E true PT1730147E (pt) | 2010-04-16 |
Family
ID=34961883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05716285T PT1730147E (pt) | 2004-03-22 | 2005-03-22 | Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7951815B2 (pt) |
| EP (1) | EP1730147B1 (pt) |
| JP (1) | JP2007529565A (pt) |
| AT (1) | ATE457027T1 (pt) |
| CA (1) | CA2560293C (pt) |
| CY (1) | CY1109962T1 (pt) |
| DE (2) | DE102004014296A1 (pt) |
| DK (1) | DK1730147T3 (pt) |
| ES (1) | ES2340502T3 (pt) |
| PL (1) | PL1730147T3 (pt) |
| PT (1) | PT1730147E (pt) |
| SI (1) | SI1730147T1 (pt) |
| WO (1) | WO2005095402A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7977358B2 (en) | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
| US8653068B2 (en) * | 2009-10-30 | 2014-02-18 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
| US9340558B2 (en) | 2007-11-02 | 2016-05-17 | Pain Therapeutics Inc. | Filamin a binding anti-inflammatory and analgesic |
| EP2488177B1 (en) * | 2008-10-31 | 2016-10-12 | Pain Therapeutics, Inc. | Filamin a binding anti-inflammatory and analgesic |
| AU2009308769B2 (en) * | 2008-10-31 | 2015-03-12 | Pain Therapeutics, Inc. | Filamin A-binding anti-inflammatory analgesic |
| US8580808B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutic, Inc. | Filamin A-binding anti-inflammatory analgesic |
| US8580809B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutics, Inc. | Filamin A-binding anti-inflammatory analgesic |
| WO2014012054A1 (en) | 2012-07-13 | 2014-01-16 | Pain Therapeutics, Inc. | Alzheimer's disease assay in a living patent |
| ES2716049T3 (es) | 2012-07-13 | 2019-06-07 | Pain Therapeutics Inc | Un método para inhibir la fosforilación de tau |
| US10092574B2 (en) | 2012-09-26 | 2018-10-09 | Valorisation-Recherche, Limited Partnership | Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof |
| US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
| WO2020048829A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 3,9-diazaspiro[5.5]undecane compounds |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
| WO2020048830A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048831A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725389A (en) * | 1971-07-02 | 1973-04-03 | American Home Prod | Adducts of delta-aminobenzylpenicillin and n-substituted-4-piperidones |
| JP2575446B2 (ja) * | 1988-02-12 | 1997-01-22 | 武田薬品工業株式会社 | トリアザスピロ化合物 |
| SI0921125T1 (en) * | 1997-12-05 | 2002-04-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives |
| PT963985E (pt) * | 1998-06-12 | 2003-06-30 | Hoffmann La Roche | Derivados de di- ou triaza-espiro(4,5)decano |
| AU1682400A (en) * | 1998-12-09 | 2000-06-26 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| AU2001262729A1 (en) * | 2000-06-14 | 2001-12-24 | Banyu Pharmaceutical Co., Ltd | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| EP1420020B1 (en) * | 2001-07-23 | 2008-05-28 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiropiperidine derivative |
-
2004
- 2004-03-22 DE DE102004014296A patent/DE102004014296A1/de not_active Withdrawn
-
2005
- 2005-03-22 DE DE502005008971T patent/DE502005008971D1/de active Active
- 2005-03-22 DK DK05716285.1T patent/DK1730147T3/da active
- 2005-03-22 ES ES05716285T patent/ES2340502T3/es active Active
- 2005-03-22 PL PL05716285T patent/PL1730147T3/pl unknown
- 2005-03-22 AT AT05716285T patent/ATE457027T1/de active
- 2005-03-22 CA CA2560293A patent/CA2560293C/en not_active Expired - Fee Related
- 2005-03-22 JP JP2007504340A patent/JP2007529565A/ja not_active Ceased
- 2005-03-22 PT PT05716285T patent/PT1730147E/pt unknown
- 2005-03-22 EP EP05716285A patent/EP1730147B1/de active Active
- 2005-03-22 SI SI200530982T patent/SI1730147T1/sl unknown
- 2005-03-22 WO PCT/EP2005/003029 patent/WO2005095402A1/de active Application Filing
-
2006
- 2006-09-22 US US11/525,057 patent/US7951815B2/en not_active Expired - Fee Related
-
2010
- 2010-04-09 CY CY20101100325T patent/CY1109962T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007529565A (ja) | 2007-10-25 |
| CA2560293A1 (en) | 2005-10-13 |
| DE102004014296A1 (de) | 2005-10-06 |
| DK1730147T3 (da) | 2010-05-31 |
| EP1730147B1 (de) | 2010-02-03 |
| DE502005008971D1 (de) | 2010-03-25 |
| ES2340502T3 (es) | 2010-06-04 |
| ATE457027T1 (de) | 2010-02-15 |
| SI1730147T1 (sl) | 2010-05-31 |
| PL1730147T3 (pl) | 2010-07-30 |
| WO2005095402A9 (de) | 2009-06-11 |
| WO2005095402A1 (de) | 2005-10-13 |
| US20070015784A1 (en) | 2007-01-18 |
| EP1730147A1 (de) | 2006-12-13 |
| US7951815B2 (en) | 2011-05-31 |
| CA2560293C (en) | 2013-01-22 |
| CY1109962T1 (el) | 2014-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1730147E (pt) | Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade | |
| SI1730144T1 (sl) | Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on | |
| PT1778680E (pt) | Derivados espirocíclicos de ciclo-hexano | |
| TW200508214A (en) | Novel compounds | |
| TW200606162A (en) | Pyrazolopyridine derivatives | |
| TW200730525A (en) | Therapeutic agents | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| TW200738658A (en) | Novel compounds | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| TW200626553A (en) | Novel compounds | |
| TW200745122A (en) | New compounds I | |
| TW200605888A (en) | Novel compounds | |
| TW200639156A (en) | New compounds | |
| PL1869038T3 (pl) | Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych | |
| TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| TW200728300A (en) | Therapeutic agents | |
| MY146802A (en) | Novel drugs for treating respiratory diseases | |
| TW200745133A (en) | New compounds II | |
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
| MXPA05013368A (es) | Derivados de indolilo biciclico y metodos para su uso como agentes serotonergicos. | |
| NO20072090L (no) | Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II | |
| ZA200605653B (en) | Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours | |
| TW200616970A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| TW200621750A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| UA87327C2 (ru) | Производные бензимидазола, композиция, которая их содержит, их получение и применение |